News | April 11, 2026
Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The presentations will showcase previously undisclosed data highlighting the expanding potential of Actinium’s Ac-225 radiotherapy platform across both solid tumors and hematologic malignancies
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
Experts also underscored the growing role of technologies such as tele-neurorehabilitation, robotics, and AI-driven therapies in improving recovery outcomes
Punya Salila Srivastava commends sanitation, waste management and infection control measures, while inaugurating a new G+9 undergraduate girls’ hostel
Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP
The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
Subscribe To Our Newsletter & Stay Updated
